The stock price of Usana Health Sciences Inc (NYSE: USNA) has jumped by 9.71 compared to previous close of 41.52. Despite this, the company has seen a gain of 4.23% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-30 that USANA Health Sciences (USNA) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.95 per share a year ago.
Is It Worth Investing in Usana Health Sciences Inc (NYSE: USNA) Right Now?
Usana Health Sciences Inc (NYSE: USNA) has a higher price-to-earnings ratio of 13.81x compared to its average ratio. USNA has 36-month beta value of 0.94. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for USNA is 11.28M, and currently, short sellers hold a 2.31% ratio of that float. The average trading volume of USNA on May 02, 2024 was 85.71K shares.
USNA’s Market Performance
USNA’s stock has seen a 4.23% increase for the week, with a -2.34% drop in the past month and a -2.71% fall in the past quarter. The volatility ratio for the week is 3.12%, and the volatility levels for the past 30 days are at 2.40% for Usana Health Sciences Inc The simple moving average for the past 20 days is 2.71% for USNA’s stock, with a -13.55% simple moving average for the past 200 days.
Analysts’ Opinion of USNA
Jefferies, on the other hand, stated in their research note that they expect to see USNA reach a price target of $53, previously predicting the price at $78. The rating they have provided for USNA stocks is “Underperform” according to the report published on July 07th, 2022.
DA Davidson gave a rating of “Neutral” to USNA, setting the target price at $86 in the report published on April 14th of the previous year.
USNA Trading at -2.65% from the 50-Day Moving Average
After a stumble in the market that brought USNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.55% of loss for the given period.
Volatility was left at 2.40%, however, over the last 30 days, the volatility rate increased by 3.12%, as shares surge +0.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.00% lower at present.
During the last 5 trading sessions, USNA rose by +4.23%, which changed the moving average for the period of 200-days by -25.73% in comparison to the 20-day moving average, which settled at $44.35. In addition, Usana Health Sciences Inc saw -15.02% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at USNA starting from Guest Kevin, who sale 11,011 shares at the price of $49.00 back on Mar 11 ’24. After this action, Guest Kevin now owns 10,491 shares of Usana Health Sciences Inc, valued at $539,539 using the latest closing price.
Noot Walter, the CHIEF OPERATING OFFICER of Usana Health Sciences Inc, sale 5,240 shares at $49.05 during a trade that took place back on Mar 08 ’24, which means that Noot Walter is holding 0 shares at $257,022 based on the most recent closing price.
Stock Fundamentals for USNA
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.81 for the gross margin
The net margin for Usana Health Sciences Inc stands at 0.07. The total capital return value is set at 0.18. Equity return is now at value 13.69, with 10.38 for asset returns.
Currently, EBITDA for the company is 113.47 million with net debt to EBITDA at -3.61. When we switch over and look at the enterprise to sales, we see a ratio of 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.51.
Conclusion
To put it simply, Usana Health Sciences Inc (USNA) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
